Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
April 28, 2025
Identification of potent and broadly-neutralizing antibodies against sarbecoviruses including SARS-CoV-1 and SARS-CoV-2
From the Overbaugh lab, Human Biology Division
¿Necesito otra vacuna de refuerzo contra el SRAS-CoV-2?
Del Dr. Bo Zhang y laboratorios colaboradores, División de Vacunas y Enfermedades Infecciosas
How protective antibodies get in malaria’s way
Fred Hutch researchers’ structural insights help reveal weak spot in parasite’s mode of attack, could guide vaccine design
Laying the groundwork for a new cancer-preventive vaccine
Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma
Going straight to the source in defense against infant RSV
New anti-idiotype antibody a first step in possible strategy to build infant immunity during vulnerable window
Mining single cell transcriptomes for antibody gold
From the Goo Lab, Vaccine and Infectious Disease Division
Escaping flavivirus-neutralizing antibodies
From the Goo lab, Vaccine and Infectious Disease Division, and the Bloom lab, Basic Science Division
Unveiling HIV’s immune evasion tactics by identifying mutations that escape antibody neutralization
From the Bloom Lab, Basic Sciences Division
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
A new path forward: A potential route to effective HIV vaccines
From the Overbaugh Lab, Human Biology Division
How studies of coronavirus immunity can inform better vaccines, treatments
Scientists look for broad-acting antibodies that could protect against new variants of SARS-CoV-2 — and maybe a future SARS-3
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
All immunogens are not created equal
From the Stamatatos lab, Vaccine and Infectious Disease Division
Multi-step HIV-1 vaccines
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Screening with bioinformatics for new dengue cross-serotype antibodies
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Creating antibodies with antibodies
From the McGuire, Taylor, and Stamatatos labs, Vaccine and Infectious Disease Division
Machine learning predicts HIV pseudovirus antibody neutralization
From the Gilbert group, Vaccine and Infectious Disease Division
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells